| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 09/07/2011 | CN101389751B Lactic acid bacterium capable of producing gamma-aminobutyric acid |
| 09/07/2011 | CN101381740B Recombinant plasmid and genetic engineering bacteria for producing succinic acid, production method and use thereof |
| 09/07/2011 | CN101372681B Streptomyces bacterial strain having activity producing C-13 substituted nemadectin |
| 09/07/2011 | CN101353689B Method for enhancing yield of ganoderma triterpene in ganoderma lucidum fermentation liquor |
| 09/07/2011 | CN101338294B Acinetobacter spp AUH-JLM455 and process preparing S-equol by conversion thereof |
| 09/07/2011 | CN101326972B Directly thrown leaven for effectively degrading nitrite in pickled vegetables and preparation thereof |
| 09/07/2011 | CN101230366B Method for producing L-glutamic acid by fermentation accompanied by precipitation |
| 09/07/2011 | CN101210234B Ocean micro-alga delta5 aliphatic acid desaturase and application thereof |
| 09/07/2011 | CN101205526B Method for rapidly culturing anaerobic ammonium oxidation bacteria by up-flow type anaerobic sludge bed reactor |
| 09/07/2011 | CN101184836B Surface activity biological catalyst for remediation of recalcitrant organics and heavy metal |
| 09/07/2011 | CN101167758B Method for preparing antiviral natural polymerization polysaccharide and oligosaccharide |
| 09/07/2011 | CN101126073B Sorangium cellulosum, preparation method and application for Phoxalone fermented by the same |
| 09/07/2011 | CN101058805B Method of producing mutation procarboxypeptidase B and mutation carboxypeptidase B |
| 09/07/2011 | CN101003789B Bacterium agent of engineering bacterium of gene recombination for spider poison peptide |
| 09/06/2011 | US8013126 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer |
| 09/06/2011 | US8013118 Lynx polypeptides |
| 09/06/2011 | US8013114 Fusion proteins based upon somatostatin receptors |
| 09/06/2011 | US8013113 FRET protease assays for clostridial toxins |
| 09/06/2011 | US8012931 Modified FGF-21 polypeptides and their uses |
| 09/06/2011 | US8012748 Peripheral nervous system specific sodium channel nucleic acids |
| 09/06/2011 | US8012739 Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA synthetase pairs |
| 09/06/2011 | US8012734 Cellulase variants with reduced inhibition by glucose |
| 09/06/2011 | US8012732 Fungal lypolytic and amylase enzyme composition and methods using the same |
| 09/06/2011 | US8012731 Phosphodiesterase and gene thereof |
| 09/06/2011 | US8012729 Mutant glucose dehydrogenase |
| 09/06/2011 | US8012726 Method of making bioethanol by using glucose isomerase mutants |
| 09/06/2011 | US8012725 Method for the production of optically-active alcohols |
| 09/06/2011 | US8012723 Process for the production of macrolides using a novel strain, Streptomyces sp. BICC 7522 |
| 09/06/2011 | US8012716 Animal protein-free medium; making and purifying botulinum toxin |
| 09/06/2011 | US8012715 Methods for production of proteins |
| 09/06/2011 | US8012479 Recombinant toxin fragments |
| 09/06/2011 | US8012476 Molecules with extended half-lives, compositions and uses thereof |
| 09/06/2011 | US8012464 Chimeric colony stimulating factor for use in treatment and prevention of cell proliferative, blood, inflammatory and nervous system disorders |
| 09/06/2011 | CA2702204C Alpha-amylase mutants with altered properties |
| 09/06/2011 | CA2452260C Novel variants and exons of the glyt1 transporter |
| 09/06/2011 | CA2438230C Mixture of bacilllus thuringiensis subspecies israelensis and bacillus sphaericus for management of resistance to mosquito larvicides |
| 09/06/2011 | CA2309133C Nucleic acid molecules which encode proteins having fructosyl transferase activity and methods for producing long-chain inulin |
| 09/01/2011 | WO2011106778A1 Transgenic algae engineered for higher performance |
| 09/01/2011 | WO2011106576A2 Methods and compositions for enhanced enzyme activity in fermenting microorganisms |
| 09/01/2011 | WO2011106491A2 Isolated bacterial strain of the genus burkholderia and pesticidal metabolites therefrom |
| 09/01/2011 | WO2011106389A1 Method for increasing n-glycosylation site occupancy on therapeutic glycoproteins produced in pichia pastoris |
| 09/01/2011 | WO2011106043A2 Improved microbial fuel cell |
| 09/01/2011 | WO2011105335A1 Method for constructing novel bacterium belonging to the genus bifidobacterium |
| 09/01/2011 | WO2011105241A1 Method for producing glucuronic acid conjugate using saccharomyces cerevisiae |
| 09/01/2011 | WO2011104630A1 Enzymes from conidiobolus brefeldianus and process for preparation thereof |
| 09/01/2011 | WO2011085367A3 Non-replicating microorganisms as post-biotics |
| 09/01/2011 | WO2011080663A3 Recombinant bacteria capable of removing chemical species of mercury (ii), cadmium and copper in the presence of other heavy metals from contaminated locations, product for bioremediation, process for the obtainment of the product and method of application for bioremediation |
| 09/01/2011 | WO2011080129A3 Detoxification with reducing agents |
| 09/01/2011 | US20110214192 Photoconvertible fluorescent proteins |
| 09/01/2011 | US20110213164 Novel compound ceramidastin, method for producing the same, and use of the same |
| 09/01/2011 | US20110213142 Method for Producing Biological Heme Iron, and Iron Supplementing Composition Containing the Heme Iron Produced By Same |
| 09/01/2011 | US20110213130 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 09/01/2011 | US20110213128 Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer |
| 09/01/2011 | US20110212989 Therapeutic methods and compositions involving isoflavones |
| 09/01/2011 | US20110212838 Sulfonylurea-Responsive Repressor Proteins |
| 09/01/2011 | US20110212529 Muscle-specific expression vectors |
| 09/01/2011 | US20110212528 Novel substitution mutant receptors and their use in an ecdysone receptor-based inducible gene expression system |
| 09/01/2011 | US20110212508 Novel Synthetic Expression Vehicle |
| 09/01/2011 | US20110212507 Methods for increasing product yields |
| 09/01/2011 | US20110212506 Nitrile hydratase variant |
| 09/01/2011 | US20110212505 BGL3 Beta-Glucosidase and Nucleic Acids Encoding the Same |
| 09/01/2011 | US20110212504 Recombinant expression of carboxylesterases |
| 09/01/2011 | US20110212502 [NiFe]-Hydrogenases Having an Improved Resistance to Dioxygen, Process for Obtaining Them and Their Applications |
| 09/01/2011 | US20110212498 Light-driven co2 reduction to organic compounds to serve as fuels or as industrial half products by an autotroph containing a fermentative gene cassette |
| 09/01/2011 | US20110212497 Method for production of polylactate using recombinant microorganism |
| 09/01/2011 | US20110212458 Methods for Production of Xylitol in Microorganisms |
| 09/01/2011 | US20110212449 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
| 09/01/2011 | US20110212241 Modified amylases, nucleic acids encoding those amylases and uses thereof |
| 09/01/2011 | US20110212223 Mutants of lactobacillus casei defective in carbon catabolism regulation |
| 09/01/2011 | US20110212164 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/01/2011 | US20110212132 Pathogen for bacterial poultry disease |
| 09/01/2011 | US20110212120 Ykur polynucleotides and polypeptides |
| 09/01/2011 | US20110212117 Influenza hemagglutinin and neuraminidase variants |
| 09/01/2011 | US20110212109 Abeta CONFORMER SELECTIVE ANTI-Abeta GLOBULOMER MONOCLONAL ANTIBODIES |
| 09/01/2011 | US20110212108 Neuregulin/erbb signaling and integrin |
| 09/01/2011 | US20110212106 Hiv-1 neutralizing antibodies and uses thereof |
| 09/01/2011 | US20110212098 Novel Melanoma Antigen Peptide and Uses Thereof |
| 09/01/2011 | US20110212096 Anti-p-selectin antibodies and methods of their use and identification |
| 09/01/2011 | US20110212094 Dual variable domain immunoglobulins and uses thereof |
| 09/01/2011 | US20110212084 Binding members for ige molecules |
| 09/01/2011 | US20110212058 Targeted modulation of gene expression |
| 09/01/2011 | US20110212023 TADG-15: an extracellular serine protease overexpossed in carcinomas |
| 09/01/2011 | CA2791141A1 Isolated bacterial strain of the genus burkholderia and pesticidal metabolites therefrom |
| 09/01/2011 | CA2790414A1 Method for constructing novel bacterium belonging to the genus bifidobacterium |
| 09/01/2011 | CA2788992A1 Method for increasing n-glycosylation site occupancy on therapeutic glycoproteins produced in pichia pastoris |
| 08/31/2011 | EP2361993A1 Method for obtaining nucleic acids from microbial samples |
| 08/31/2011 | EP2361981A1 RNA sequence-specific mediators of RNA interference |
| 08/31/2011 | EP2361978A1 Polypeptides capable of eliciting an immune reaction against cancer |
| 08/31/2011 | EP2361966A1 Mesoderm and definitive endoderm cell populations |
| 08/31/2011 | EP2361965A2 Small molecule anti-cancer compounds & related production process |
| 08/31/2011 | EP2361635A2 Anti IgE vaccines |
| 08/31/2011 | EP2361312A1 Optimised fermentation media |
| 08/31/2011 | EP2022850B1 Flavin adenine dinucleotide-binding glucose dehydrogenase |
| 08/31/2011 | EP1523320B1 Megasphaera elsdenii strain and its uses |
| 08/31/2011 | EP1446422B1 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same |
| 08/31/2011 | EP1402015B1 A soluble complex comprising a retroviral surface glycoprotein and fkpa or slyd |
| 08/31/2011 | EP1334185B1 Method for producing proteins by electroporation |
| 08/31/2011 | EP1095140B1 Neurotrophic factors |
| 08/31/2011 | CN102171346A A method for producing purine ribonucleosides and ribonucleotides |
| 08/31/2011 | CN102171338A Novel protein having fructosyl valyl histidine oxidase activity and modified product thereof, and use of the protein or the modified product |